• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二维 H NMR 弛豫谱评估骨组织细胞构筑。

Assessment of bone tissue cytoarchitectonics by 2D H NMR relaxometry maps.

机构信息

George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 38 Gheorghe Marinescu Str., Targu Mures 540139, Romania.

Technical University of Cluj-Napoca, 28 Memorandumului Str., Cluj-Napoca-Napoca, 400114, Romania.

出版信息

J Biol Phys. 2024 Dec;50(3-4):255-269. doi: 10.1007/s10867-024-09658-2. Epub 2024 Jun 27.

DOI:10.1007/s10867-024-09658-2
PMID:38935192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11492200/
Abstract

Bone is a complex tissue that fulfills the role of a resistance structure. This quality is most commonly assessed by bone densitometry, but bone strength may not only be related to bone mineral density but also to the preservation of bone cytoarchitectonics. The study included two groups of rats, ovariectomized and non-ovariectomized. Each group was divided into three batches: control, simvastatin-treated, and fenofibrate-treated. In the ovariectomized group, hypolipidemic treatment was instituted at 12 weeks post ovariectomy. One rat from each of the 6 batches was sacrificed 8 weeks after the start of treatment in the group. The experimental study was performed using a Bruker Minispec mq 20 spectrometer operating at a frequency of 20 MHz, subsequently also performed by H T-T molecular exchange maps. The results were represented by T-T molecular exchange maps that showed, comparatively, both pore size and their interconnectivity at the level of the femoral epiphysis, being able to evaluate both the effect of estrogen on bone tissue biology and the effect of the lipid-lowering medication, simvastatin, and fenofibrate, in both the presence and absence of estrogen. T-T molecular exchange maps showed that the absence of estrogen results in an increase in bone tissue pore size and interconnectivity. In the presence of estrogen, lipid-lowering medication, both simvastatin and fenofibrate alter bone tissue cytoarchitectonics by reducing pore interconnectivity. In the absence of estrogen, fenofibrate improves bone tissue cytoarchitectonics, the T-T molecular exchange map being similar to that of non-osteoporotic bone tissue.

摘要

骨是一种复杂的组织,起到抵抗结构的作用。这种特性通常通过骨密度测定来评估,但骨强度不仅可能与骨矿物质密度有关,还可能与骨细胞结构的保存有关。本研究包括两组大鼠,去卵巢组和非去卵巢组。每组又分为三组:对照组、辛伐他汀治疗组和非诺贝特治疗组。在去卵巢组中,在去卵巢后 12 周开始进行降脂治疗。每组的 6 个批次中的每批都有一只大鼠在治疗开始后 8 周被处死。该实验研究使用 Bruker Minispec mq 20 光谱仪在 20 MHz 的频率下进行,随后还进行了 HT-T 分子交换图谱分析。结果以 T-T 分子交换图谱表示,这些图谱比较了股骨骨骺水平的孔径大小及其连通性,能够评估雌激素对骨组织生物学的影响,以及降脂药物辛伐他汀和非诺贝特在存在和不存在雌激素的情况下的作用。T-T 分子交换图谱显示,雌激素缺乏会导致骨组织孔径和连通性增加。在存在雌激素的情况下,降脂药物辛伐他汀和非诺贝特都会通过减少孔径连通性来改变骨组织细胞结构。在缺乏雌激素的情况下,非诺贝特可改善骨组织细胞结构,T-T 分子交换图谱类似于非骨质疏松性骨组织。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e42/11492200/5c9d5b9707be/10867_2024_9658_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e42/11492200/7af332eb2123/10867_2024_9658_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e42/11492200/b8e2ca9912df/10867_2024_9658_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e42/11492200/c803f2e8c45c/10867_2024_9658_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e42/11492200/caf0735a2503/10867_2024_9658_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e42/11492200/3e5fb05bfb42/10867_2024_9658_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e42/11492200/db8e9523597b/10867_2024_9658_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e42/11492200/5c9d5b9707be/10867_2024_9658_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e42/11492200/7af332eb2123/10867_2024_9658_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e42/11492200/b8e2ca9912df/10867_2024_9658_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e42/11492200/c803f2e8c45c/10867_2024_9658_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e42/11492200/caf0735a2503/10867_2024_9658_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e42/11492200/3e5fb05bfb42/10867_2024_9658_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e42/11492200/db8e9523597b/10867_2024_9658_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e42/11492200/5c9d5b9707be/10867_2024_9658_Fig7_HTML.jpg

相似文献

1
Assessment of bone tissue cytoarchitectonics by 2D H NMR relaxometry maps.二维 H NMR 弛豫谱评估骨组织细胞构筑。
J Biol Phys. 2024 Dec;50(3-4):255-269. doi: 10.1007/s10867-024-09658-2. Epub 2024 Jun 27.
2
Evaluation of the Influence of Hypolipidemic Medication on Albino Wistar Rats' Bone Tissue by NMR Diffusiometry.磁共振扩散张量成像评价降脂药物对白化 Wistar 大鼠骨组织的影响。
Medicina (Kaunas). 2024 May 31;60(6):918. doi: 10.3390/medicina60060918.
3
Ovariectomized rats' femur treated with fibrates and statins. Assessment of pore-size distribution by ¹H-NMR relaxometry.用贝特类药物和他汀类药物治疗的去卵巢大鼠股骨。通过¹H-NMR弛豫测量法评估孔径分布。
Rom J Morphol Embryol. 2015;56(2 Suppl):743-52.
4
Callus formation in albino Wistar rats after femur fracture assessed by visible spectroscopy.可见分光光度法评估白化 Wistar 大鼠股骨骨折后骨痂形成。
Biochem Biophys Res Commun. 2022 Dec 17;634:168-174. doi: 10.1016/j.bbrc.2022.09.114. Epub 2022 Oct 7.
5
Effects of pioglitazone and fenofibrate co-administration on bone biomechanics and histomorphometry in ovariectomized rats.吡格列酮与非诺贝特联合给药对去卵巢大鼠骨生物力学和组织形态计量学的影响。
J Bone Miner Metab. 2015 Nov;33(6):625-41. doi: 10.1007/s00774-014-0632-4. Epub 2014 Dec 23.
6
Simvastatin induces estrogen receptor-alpha expression in bone, restores bone loss, and decreases ERα expression and uterine wet weight in ovariectomized rats.辛伐他汀可诱导骨组织中雌激素受体-α的表达,可恢复骨丢失,并降低去卵巢大鼠的 ERα 表达和子宫湿重。
J Bone Miner Metab. 2011 Jul;29(4):396-403. doi: 10.1007/s00774-010-0231-y. Epub 2010 Nov 10.
7
Effects of simvastatin and fenofibrate on butyrylcholinesterase activity in the brain, plasma, and liver of normolipidemic and hyperlipidemic rats.辛伐他汀和非诺贝特对正常血脂和高脂血症大鼠脑、血浆及肝脏中丁酰胆碱酯酶活性的影响。
Arh Hig Rada Toksikol. 2019 Mar 1;70(1):30-35. doi: 10.2478/aiht-2019-70-3215.
8
Comparative impact of systemic delivery of atorvastatin, simvastatin, and lovastatin on bone mineral density of the ovariectomized rats.阿托伐他汀、辛伐他汀和洛伐他汀全身给药对去卵巢大鼠骨密度的比较影响。
Endocrine. 2018 Apr;60(1):138-150. doi: 10.1007/s12020-018-1531-6. Epub 2018 Jan 25.
9
The effects of combined human parathyroid hormone (1-34) and simvastatin treatment on osseous integration of hydroxyapatite-coated titanium implants in the femur of ovariectomized rats.人甲状旁腺激素(1-34)与辛伐他汀联合治疗对去卵巢大鼠股骨中羟基磷灰石涂层钛植入物骨整合的影响。
Injury. 2015 Nov;46(11):2164-9. doi: 10.1016/j.injury.2015.08.034. Epub 2015 Sep 14.
10
Effects of simvastatin on bone regeneration in the mandibles of ovariectomized rats and on blood cholesterol levels.辛伐他汀对去卵巢大鼠下颌骨骨再生及血液胆固醇水平的影响。
J Oral Sci. 2002 Dec;44(3-4):117-24. doi: 10.2334/josnusd.44.117.

本文引用的文献

1
Bioinformatic analysis of the molecular mechanisms underlying the progression of bone defects.骨缺损进展潜在分子机制的生物信息学分析
Front Med (Lausanne). 2023 Jun 8;10:1157099. doi: 10.3389/fmed.2023.1157099. eCollection 2023.
2
Callus formation in albino Wistar rats after femur fracture assessed by visible spectroscopy.可见分光光度法评估白化 Wistar 大鼠股骨骨折后骨痂形成。
Biochem Biophys Res Commun. 2022 Dec 17;634:168-174. doi: 10.1016/j.bbrc.2022.09.114. Epub 2022 Oct 7.
3
Bone Health in Patients with Dyslipidemias: An Underestimated Aspect.
血脂异常患者的骨骼健康:一个被低估的方面。
Int J Mol Sci. 2022 Jan 31;23(3):1639. doi: 10.3390/ijms23031639.
4
Update on Osteoporosis Screening and Management.骨质疏松症筛查和管理的最新进展。
Med Clin North Am. 2021 Nov;105(6):1117-1134. doi: 10.1016/j.mcna.2021.05.016. Epub 2021 Sep 8.
5
Postmenopausal Osteoporosis: Latest Guidelines.绝经后骨质疏松症:最新指南
Endocrinol Metab Clin North Am. 2021 Jun;50(2):167-178. doi: 10.1016/j.ecl.2021.03.009.
6
Association of dyslipidaemia with osteoporosis in postmenopausal women.绝经后妇女血脂异常与骨质疏松症的关系。
J Int Med Res. 2021 Mar;49(3):300060521999555. doi: 10.1177/0300060521999555.
7
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?新心血管预防指南:2021 年需要二级预防的患者如何最佳管理血脂异常和心血管风险?
Atherosclerosis. 2021 Feb;319:51-61. doi: 10.1016/j.atherosclerosis.2020.12.013. Epub 2021 Jan 18.
8
Management of hypertriglyceridemia.高甘油三酯血症的管理。
BMJ. 2020 Oct 12;371:m3109. doi: 10.1136/bmj.m3109.
9
Diagnosis of osteoporosis in statin-treated patients is dose-dependent.他汀类药物治疗患者的骨质疏松症诊断与剂量相关。
Ann Rheum Dis. 2019 Dec;78(12):1706-1711. doi: 10.1136/annrheumdis-2019-215714. Epub 2019 Sep 26.
10
Positive effects of low LDL-C and statins on bone mineral density: an integrated epidemiological observation analysis and Mendelian randomization study.低 LDL-C 和他汀类药物对骨密度的积极影响:一项综合的流行病学观察分析和孟德尔随机化研究。
Int J Epidemiol. 2020 Aug 1;49(4):1221-1235. doi: 10.1093/ije/dyz145.